Operating Lease, Liability, Current of REGENEREX PHARMA, INC. from 30 Jun 2023 to 30 Sep 2025

Taxonomy & unit: us-gaap: USD
Description: Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.
Summary: REGENEREX PHARMA, INC. quarterly Operating Lease, Liability, Current in USD history and change rate from 30 Jun 2023 to 30 Sep 2025.
REGENEREX PHARMA, INC. Operating Lease, Liability, Current for the quarter ending 30 Sep 2025 was $191,181, a 15% increase year-over-year.
Source SEC data: View on sec.gov

Operating Lease, Liability, Current, Quarterly (USD)

Operating Lease, Liability, Current, YoY Quarterly Change (%)

REGENEREX PHARMA, INC. Quarterly Operating Lease, Liability, Current (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2025	$191,181	+$24,873	+15%	30 Sep 2025	10-Q	17 Nov 2025	2025	Q2
Q2 2025	$167,673	-$6,586	-3.8%	30 Jun 2025	10-Q	14 Aug 2025	2024	Q1
Q1 2025	$181,894	+$53,630	+42%	31 Mar 2025	10-Q	17 Nov 2025	2025	Q2
Q4 2024	$177,422	+$25,376	+17%	31 Dec 2024	10-Q	07 Feb 2025	2024	Q3
Q3 2024	$166,308	+$4,013	+2.5%	30 Sep 2024	10-Q	04 Nov 2024	2024	Q2
Q2 2024	$174,259	+$37,376	+27%	30 Jun 2024	10-Q	07 Aug 2024	2024	Q1
Q1 2024	$128,264			31 Mar 2024	10-K	30 Jun 2025	2024	FY
Q4 2023	$152,046			31 Dec 2023	10-Q	05 Feb 2024	2023	Q3
Q3 2023	$162,295			30 Sep 2023	10-Q	08 Nov 2023	2023	Q2
Q2 2023	$136,883			30 Jun 2023	10-Q	14 Aug 2023	2023	Q1

* An asterisk sign (*) next to the value indicates that the value is likely invalid.